Literature DB >> 22345022

Efficiency considerations of donor fatigue, universal access to ARTs and health systems.

Karen A Grépin1.   

Abstract

OBJECTIVES: To investigate trends in official development assistance for health, HIV and non-HIV activities over time and to discuss the efficiency implications of these trends in the context of achieving universal access to treatment and health systems.
METHODS: Official development assistance for health, HIV programmes and non-HIV programmes were tracked using data from 2000 to 2009. A review of the literature on efficiency, treatment and health systems was conducted.
FINDINGS: The rate of growth of donor funding to HIV programmes has slowed in recent years at levels below those required to sustain programmes and to move towards universal access to treatment. These trends are likely due to increased pressure on foreign aid budgets and donor fatigue for HIV programmes.
CONCLUSIONS: There is great need to consider how the limited resources available can be used most efficiently to increase the number of lives saved and to ensure that these resources also benefit health systems. Improving efficiency is much more than just improving the productive efficiency and also about ensuring that resources are going to where they will be the most beneficial and making investments that are the most efficient over time. These choices may be essential to achieving the goal of universal access to treatment as well as the sustainability of these programmes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22345022     DOI: 10.1136/sextrans-2011-050148

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  7 in total

1.  Beyond cost-effectiveness, morbidity and mortality: a comprehensive evaluation of priority setting for HIV programming in Uganda.

Authors:  Lydia Kapiriri; Na-Mee Lee; Lauren Jean Wallace; Brendan Kwesiga
Journal:  BMC Public Health       Date:  2019-04-01       Impact factor: 3.295

2.  Changing patterns of gender inequities in childhood mortalities during the Sustainable Development Goals era in Nigeria: findings from an artificial neural network analysis.

Authors:  Daniel Adedayo Adeyinka; Pammla Margaret Petrucka; Elon Warnow Isaac; Nazeem Muhajarine
Journal:  BMJ Open       Date:  2021-01-29       Impact factor: 2.692

3.  ART treatment costs and retention in care in Kenya: a cohort study in three rural outpatient clinics.

Authors:  Bruce A Larson; Margaret Bii; Sarah Henly-Thomas; Kelly McCoy; Fredrick Sawe; Douglas Shaffer; Sydney Rosen
Journal:  J Int AIDS Soc       Date:  2013-01-02       Impact factor: 5.396

4.  Are long-lasting insecticide-treated bednets and water filters cost-effective tools for delaying HIV disease progression in Kenya?

Authors:  Stéphane Verguet; James G Kahn; Elliot Marseille; Aliya Jiwani; Eli Kern; Judd L Walson
Journal:  Glob Health Action       Date:  2015-06-10       Impact factor: 2.996

5.  Allocating external financing for health: a discrete choice experiment of stakeholder preferences.

Authors:  Karen A Grépin; Crossley B Pinkstaff; Arne Risa Hole; Klara Henderson; Ole Frithjof Norheim; John-Arne Røttingen; Trygve Ottersen
Journal:  Health Policy Plan       Date:  2018-02-01       Impact factor: 3.344

6.  Exploring the evolution of policies for universal antiretroviral therapy and their implementation across three sub-Saharan African countries: Findings from the SHAPE study.

Authors:  Moses Kumwenda; Morten Skovdal; Alison Wringe; Thoko Kalua; Hadija Kweka; John Songo; Farida Hassan; Rujeko Samanthia Chimukuche; Mosa Moshabela; Janet Seeley; Jenny Renju
Journal:  Glob Public Health       Date:  2020-12-04

Review 7.  Immunological Treatment Failure Among Adult Patients Receiving Highly Active Antiretroviral Therapy in East Africa: A Systematic Review and Meta-Analysis.

Authors:  Getenet Dessie; Henok Mulugeta; Fasil Wagnew; Abriham Zegeye; Dessalegn Kiross; Ayenew Negesse; Yared Asmare Aynalem; Temsgen Getaneh; Alison Ohringer; Sahai Burrowes
Journal:  Curr Ther Res Clin Exp       Date:  2021-01-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.